Targeting pathways that modify RNA to deliver novel cancer therapeutics
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 14, 2022 | Series B | $30M | 8 | Cambridge Innovation Capital Fast Track Initiative, Inc. M Ventures Pfizer Venture Investments Taiho Ventures UTokyo Innovation Platform | — | Detail |
May 3, 2022 | Grant | — | 1 | Innovate UK | — | Detail |
May 20, 2019 | Series A | £14M | 6 | Seroba Life Sciences | — | Detail |
Sep 3, 2018 | Grant | £240K | 1 | Innovate UK | — | Detail |
Jan 8, 2018 | Series A | £4M | 1 | Taiho Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cambridge Innovation Capital | Yes | Series B |
Fast Track Initiative, Inc. | Yes | Series B |
M Ventures | Yes | Series B |
Pfizer Venture Investments | Yes | Series B |
Taiho Ventures | Yes | Series B |
UTokyo Innovation Platform | Yes | Series B |
Innovate UK | Yes | Grant |
IP Group | — | Series B |
Seroba Life Sciences | — | Series B |
Imperial Innovations | — | Series A |